312 related articles for article (PubMed ID: 25918379)
1. IL-33 activates tumor stroma to promote intestinal polyposis.
Maywald RL; Doerner SK; Pastorelli L; De Salvo C; Benton SM; Dawson EP; Lanza DG; Berger NA; Markowitz SD; Lenz HJ; Nadeau JH; Pizarro TT; Heaney JD
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2487-96. PubMed ID: 25918379
[TBL] [Abstract][Full Text] [Related]
2. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc
He Z; Chen L; Souto FO; Canasto-Chibuque C; Bongers G; Deshpande M; Harpaz N; Ko HM; Kelley K; Furtado GC; Lira SA
Sci Rep; 2017 Jul; 7(1):5520. PubMed ID: 28710436
[TBL] [Abstract][Full Text] [Related]
4. Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22.
Chen Y; Vandereyken M; Newton IP; Moraga I; Näthke IS; Swamy M
PLoS Biol; 2019 Nov; 17(11):e3000540. PubMed ID: 31770366
[TBL] [Abstract][Full Text] [Related]
5. Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion.
Swietlicki EA; Bala S; Lu J; Shaker A; Kularatna G; Levin MS; Rubin DC
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G564-72. PubMed ID: 23886856
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor promotes intestinal tumorigenesis.
Wilson JM; Coletta PL; Cuthbert RJ; Scott N; MacLennan K; Hawcroft G; Leng L; Lubetsky JB; Jin KK; Lolis E; Medina F; Brieva JA; Poulsom R; Markham AF; Bucala R; Hull MA
Gastroenterology; 2005 Nov; 129(5):1485-503. PubMed ID: 16285950
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.
Cui G; Qi H; Gundersen MD; Yang H; Christiansen I; Sørbye SW; Goll R; Florholmen J
Cancer Immunol Immunother; 2015 Feb; 64(2):181-90. PubMed ID: 25324197
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.
Xu C; Reichert EC; Nakano T; Lohse M; Gardner AA; Revelo MP; Topham MK; Stafforini DM
Cancer Res; 2013 May; 73(9):2806-16. PubMed ID: 23361301
[TBL] [Abstract][Full Text] [Related]
9. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
10. Gastrin promotes intestinal polyposis through cholecystokinin-B receptor-mediated proliferative signaling and fostering tumor microenvironment.
Han YM; Park JM; Park SH; Hahm KB; Hong SP; Kim EH
J Physiol Pharmacol; 2013 Aug; 64(4):429-37. PubMed ID: 24101389
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
Shao J; Washington MK; Saxena R; Sheng H
Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
[TBL] [Abstract][Full Text] [Related]
13. Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18.
Han YM; Park JM; Cha JY; Jeong M; Go EJ; Hahm KB
Int J Cancer; 2016 May; 138(9):2247-56. PubMed ID: 26650508
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
16. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
Kettunen HL; Kettunen AS; Rautonen NE
Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
[TBL] [Abstract][Full Text] [Related]
17. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
[TBL] [Abstract][Full Text] [Related]
19. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
